AR131282A1 - Compuestos novedosos - Google Patents
Compuestos novedososInfo
- Publication number
- AR131282A1 AR131282A1 ARP230103313A ARP230103313A AR131282A1 AR 131282 A1 AR131282 A1 AR 131282A1 AR P230103313 A ARP230103313 A AR P230103313A AR P230103313 A ARP230103313 A AR P230103313A AR 131282 A1 AR131282 A1 AR 131282A1
- Authority
- AR
- Argentina
- Prior art keywords
- novel compounds
- compounds
- novel
- methods
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Abstract
La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde R¹, R², X y W son como se describen en la presente, una composición que incluye los compuestos y métodos para usar los compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22212126 | 2022-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR131282A1 true AR131282A1 (es) | 2025-03-05 |
Family
ID=84462879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230103313A AR131282A1 (es) | 2022-12-08 | 2023-12-06 | Compuestos novedosos |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4630420A1 (es) |
| JP (1) | JP2025540258A (es) |
| CN (1) | CN120303272A (es) |
| AR (1) | AR131282A1 (es) |
| TW (1) | TW202440569A (es) |
| WO (1) | WO2024121184A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US11319319B1 (en) | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| US12331048B2 (en) | 2022-10-31 | 2025-06-17 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors |
| CN121358737A (zh) * | 2023-06-03 | 2026-01-16 | 成都赜灵生物医药科技有限公司 | 并哒嗪类化合物及其用途 |
| TW202545527A (zh) | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3及glp-1a組合療法 |
| WO2025180453A1 (zh) * | 2024-02-28 | 2025-09-04 | 纽欧申医药(上海)有限公司 | 哒嗪环衍生物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022525417A (ja) | 2019-03-15 | 2022-05-13 | スカイホーク・セラピューティクス・インコーポレーテッド | 異常スプライシングを修正するための組成物および方法 |
| EP4289823A4 (en) * | 2021-02-08 | 2025-02-26 | Medshine Discovery Inc. | SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES |
-
2023
- 2023-12-06 WO PCT/EP2023/084416 patent/WO2024121184A1/en not_active Ceased
- 2023-12-06 CN CN202380083769.1A patent/CN120303272A/zh active Pending
- 2023-12-06 JP JP2025533089A patent/JP2025540258A/ja active Pending
- 2023-12-06 EP EP23818438.6A patent/EP4630420A1/en active Pending
- 2023-12-06 AR ARP230103313A patent/AR131282A1/es unknown
- 2023-12-07 TW TW112147614A patent/TW202440569A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202440569A (zh) | 2024-10-16 |
| CN120303272A (zh) | 2025-07-11 |
| WO2024121184A1 (en) | 2024-06-13 |
| JP2025540258A (ja) | 2025-12-11 |
| EP4630420A1 (en) | 2025-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023003312A1 (es) | Inhibidores de nlrp3 | |
| AR131006A1 (es) | Compuestos novedosos | |
| CL2023003154A1 (es) | Compuestos heterocíclicos | |
| AR132377A1 (es) | Compuestos novedosos | |
| CL2021001330A1 (es) | Nuevos compuestos heterocíclicos | |
| CL2022001091A1 (es) | Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco (divisional de solicitud 202001871). | |
| AR130984A1 (es) | Compuestos novedosos | |
| AR123424A1 (es) | Nuevos compuestos heterocíclicos | |
| CO2023016212A2 (es) | Derivados de triazina y su uso en el tratamiento del cáncer | |
| AR131278A1 (es) | Compuestos novedosos | |
| CL2022000802A1 (es) | Compuestos heterocíclicos de arilmetileno como bloqueadores del canal shaker de potasio kv1.3 | |
| AR132456A1 (es) | Compuestos novedosos | |
| CL2023002429A1 (es) | Derivados novedosos de pirimidin-2-il sulfonamida | |
| CL2022000019A1 (es) | Nuevos compuestos heterocíclicos | |
| CR20240203A (es) | Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2 | |
| CO2025003256A2 (es) | Derivados novedosos deuterados de pirimidin-2-il sulfonamida | |
| CL2025000126A1 (es) | Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina. | |
| CL2025000125A1 (es) | Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina. | |
| CO2024003094A2 (es) | Compuesto imidazocíclico y aplicación del mismo | |
| AR133076A1 (es) | Compuestos novedosos | |
| AR133375A1 (es) | Compuestos novedosos | |
| AR131633A1 (es) | Derivados novedosos de pirimidinil sulfonamida | |
| AR132455A1 (es) | Compuestos novedosos | |
| AR130168A1 (es) | Derivados bicíclicos de tetrahidrotiazepina | |
| AR134215A1 (es) | Compuestos de tiazol y métodos de uso |